Skip to content
drillr.ai

DOCS

Doximity, Inc.

NYSE · USHealthcareMedical - Healthcare Information Services
$21.73+0.98%

Price as of Jul 20, 2026

DOCS news

Doximity, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026

    Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026 Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2026 after market close on August 6, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page a

    Business Wire ·

  2. Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety

    Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety Doximity Ask outranked OpenEvidence, GPT-5.6 Sol, Claude Fable 5, and other frontier models Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, outperformed leading frontier AI models in the NOHARM (Numerous Options Harm Assessment for Risk in Medicine) benchmark, one of the

    Business Wire ·

  3. Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?

    Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, July 3, 2026 /PR

    PR Newswire ·

  4. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June 29, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Doximity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for inform

    ACCESSWIRE ·

  5. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Doximity, Inc. – DOCS

    NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Doximity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] (http

    Globe Newswire ·

  6. DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm PR Newswire LOS ANGELES, June 8, 2026 LOS ANGELES, June 8, 2026 /PRNewswire/ -- The Schall Law Firm (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4705843-1&h=1929577591&u=https%3A%2F%2Fschallfirm.com%2F&a=The+Schall+Law+Firm) , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or "the Company") (NYSE:

    PR Newswire ·

  7. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Doximity, Inc. (DOCS) and Encourages Stockholders to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 26, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS). Investors who purchased Doximity securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DOCS. (https://bgandg.com/DOCS/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=DOCS) (

    ACCESSWIRE ·

  8. Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Investors to Inquire about Securities Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 25, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS). Investors who purchased Doximity securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DOCS. (https://bgandg.com/DOCS/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=DOCS) (

    ACCESSWIRE ·

  9. Doximity to Present at the William Blair 46th Annual Growth Stock Conference

    Doximity to Present at the William Blair 46th Annual Growth Stock Conference Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026 at 4:40 p.m. Central Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than

    Business Wire ·

  10. Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings

    Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced an integration with Aledade, a physician‑led, national leader in value‑based care. Through the agreement, Doximity will integrate components of its HIPAA-compliant Clinical AI Suite, including its ambient notetaking tool Scribe (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.doximity.com%

    Business Wire ·

  11. Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results

    Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results Fiscal year 2026 total revenues of $644.9 million, up 13% year-over-year Fiscal year 2026 operating cash flows of $326.5 million, up 19% year-over-year Fiscal year 2026 free cash flow of $317.5 million, up 19% year-over-year Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 fourth quarter and fiscal year ended March 31, 2026. “We’re thri

    Business Wire ·

  12. Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026

    Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026 Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2026 after market close on May 13, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company’

    Business Wire ·

  13. Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist

    Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist 94% of physicians are using AI or interested, but 71% are concerned about its accuracy and reliability Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released a new report examining how physicians are adopting artificial intelligence (AI) in clinical practice. The findings show that AI adoption and interest are widespread: 94% of physicians reported they are current

    Business Wire ·